News and updates with the latest clinical trials, medical reports and interesting developments within the DMD community.
Duchenne UK is pleased to announce the launch of the DMD Hub website, the go-to website for clinical trial information for Duchenne Muscular Dystrophy (DMD) in the UK.
The DMD Hub was created by Duchenne UK and leading neuromuscular clinicians based at the John Walton Muscular Dystrophy Research Centre in Newcastle and Great Ormond Street Hospital in London. The DMD-Hub is addressing the lack of capacity in the UK for clinical trials in Duchenne Muscular Dystrophy. Our ambition is to ensure that every child diagnosed with DMD in the UK is given the opportunity to take part in research.
Pfizer has announced that the first UK-based DMD patient has been enrolled in a gene therapy trial at Newcastle Hospitals NHS Foundation, a DMD Hub site.
The DMD Hub is one of Duchenne UK’s flagship projects and has successfully expanded capacity for Duchenne muscular dystrophy (DMD) clinical trials in the UK. By funding key posts at hospital sites across the UK, many more boys are now able to take part in trials for potentially life-changing treatments.
We were delighted to welcome the following new staff to the DMD Hub network. Each team member will play an important role in running effective trials for potential DMD treatments: